(TheProudRepublic.com) – Affecting thousands of Americans who battle daily with cold and flu this season, a trusted brand for millions, Kirkland Signature is recalling thousands of boxes of cold and flu medicine due to quality control issues.
This recall affects approximately 8,640 boxes of Kirkland Signature Severe Cold & Flu Plus Congestion sold at Costco.
The Food Drug Administration’s (FDA) involvement raises concerns about government overreach and the potential impact on consumer choice.
The agency classified the recall as Class II, indicating potential temporary or medically reversible adverse health consequences.
Nevertheless, the specific quality control issues leading to the recall were kept a secret, leaving consumers in the dark about the true nature of the problem.
While the recall is not directly related to the effectiveness of phenylephrine, a key ingredient in the medicine, it comes at a time when federal regulators are scrutinizing this component.
According to the agency, the medication was recalled due to “CGMP deviations,” meaning the product was not made to the standard of the quality control regulations known as Current Good Manufacturing Practices.
An outside panel of experts previously voted against the efficacy of orally administered phenylephrine, potentially paving the way for further government intervention in over-the-counter medications.
The recalled product is a 168-count twin pack containing 112 day-use caplets and 56 night-use caplets.
The daytime capsules are designed to reduce pain and fever, suppress cough, lubricate airways, and promote decongestion.
In contrast, the evening capsules include antihistamines for throat and nasal symptoms and to induce drowsiness.
Consumers who have purchased this medicine should check their stock against the recall details.
The affected products can be identified by the National Drug Code/NDC number 63981-795-81, Lot numbers P139953 or P139815, and Expiration date: August 2026.
Those in possession of the recalled medicine are advised not to use it and to either dispose of it or return it to Costco.
As the FDA considers potentially banning oral phenylephrine due to questions about its effectiveness as a nasal decongestant, consumers should be wary of further government interference in the over-the-counter medication market.
Such actions could limit cold and flu relief options, forcing Americans to rely more heavily on prescription medications or less effective alternatives.
Copyright 2024, TheProudRepublic.com
